Empathy and aggression: two faces of ecstasy? A study of interpretative cognitive bias and mood change in ecstasy users
- 486 Downloads
As central 5-hydroxytryptamine (5-HT) is attenuated for a period following a single dose of MDMA (“ecstasy”) and low 5-HT is associated with aggression, then MDMA users may be more aggressive in the days following an acute dose of the drug.
This study therefore aimed to determine if acute use of MDMA is associated with aggression 4 and 7 days later.
Twenty-nine MDMA users and 32 controls were compared on self-rated aggression and depression on the night of drug use (day 0), 4 and 7 days later. On day 4, participants performed an interpretative bias task in which they processed ambiguous sentences that could be interpreted in either an aggressive or neutral way (e.g. “The painter drew the knife”).
MDMA users had faster response times in completing ambiguous aggressive sentences than neutral sentences; controls showed the opposite pattern of performance. In a subsequent recognition task, MDMA users were more confident in judging, and responded faster to, aggressive than neutral sentences; controls again showed the opposite pattern of effects. The level of aggressive interpretative bias positively correlated with extent of MDMA use. Midweek, MDMA users had higher self-rated aggression and depression scores than controls; on day 7, scores of both groups were similar.
MDMA users display a cognitive bias towards interpreting ambiguous information in an aggressive way a few days after taking the drug. Self-rated mid-week low mood and mid-week aggression do not persist 7 days after use of the drug. This pattern of results is consistent both with the acute and residual effects of MDMA on central 5-HT and with the notion that 5-HT plays a role in modulating human aggression.
KeywordsMDMA Ecstasy Aggression Depression Cognitive bias Interpretative bias
None of the authors have any interest, financial or otherwise, that might potentially bias their work. We thank Dr. Suzanne Verheyden for comments on an earlier draft of this article.
- Beck AT (1978) The Beck Depression Inventory (BDI). The Psychological Corporation, Harcourt Brace JovanovitzGoogle Scholar
- Bond AJ, Lader MH (1974) The use of analogue scales in rating subjective feelings. Br J Med Psychol 47:211–218Google Scholar
- Buss AH, Perry M (1992) The aggression questionnaire. J Person Soc Psychol 63:452–459Google Scholar
- Cleare AJ, Bond AJ (1995) The effect of tryptophan depletion and enhancement on subjective and behavioural aggression in normal male subjects. Psychopharmacology 118:72–81Google Scholar
- Gerra G, Zaimovic A, Giucastro G, Maestri D, Monica C, Sartori R, Caccavari R, Delssignore R (1998) Serotonergic function after 3,4 methylenedioxymethamphetamine (“ecstasy”) in humans. Int Clin Pharmacol 13:1–9Google Scholar
- Gerra G, Zaimovic A, Ampollinin R, Giusti F, Delsignore R, Raggi MA, Laviola G, Macchia T, Brambilla F (2001) Experimentally induced aggressive behaviour in subjects with 3,4 methylenedioxymethamphetamine (“ecstasy”) use history. Psychobiological correlates. J Subst Misuse 13:471–491CrossRefGoogle Scholar
- Linnoila M, Virkkunen M, George T, Higley D (1993) Impulse control disorders. Int Clin Psychopharmacol 8:53–56Google Scholar
- McCann UD, Ridenour A, Shaham Y, Ricaurte GA (1994) Serotonin neurotoxicity after (±)3,4-methylenedioxymethamphetamine (MDMA; “ecstasy”): a controlled study in humans Neuropsychopharmacology 10:129–138Google Scholar
- McKenna DJ, Peroutka SJ (1990) Neurochemistry and neurotoxicity of 3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”) J Neurochem 541:14–22Google Scholar
- Novaco RW (1978) Anger and coping with stress: Cognitive behavioural intervention. In: Foreyt JP, Rathjen P (eds) Cognitive behavioural therapy: research and application. Plenum Press, New York/LondonGoogle Scholar
- Young SN, Leyton M (2002) The role of serotonin in human mood and social interaction: insight from altered tryptophan levels. Pharmacol Biochem Behav 71:857–865Google Scholar